retatrutide safety trial results Results: 24% Weight Loss in 48 Weeks VisualAbstract: Retatrutide reduces body weight

This triple-receptor activity is designed to metabolic processes, facilitating body recomposition and weight management

Then, in September, the Trump Administration launched a crackdown on deceptive direct-to-consumer drug advertising, resulting in the FDA publishing over 55 warning letters to online sellers of compounded versions of GLP-1 medications that called for the removal of false and misleading promotional statements, claims of clinically proven weight-loss treatments, and using the words FDA-approved in advertising copy

Discussion at the American Heart Association session underscored the stakes of such decisions, as it was noted that an estimated 6.6 million American adults meet the inclusion criteria for the SELECT trial

Summer shipping may require cold packs to prevent heat exposure

doi: 10.1016/j.cub.2016.12.038